Aurinia Pharmaceuticals Inc.

(AUP:PUR)

By |

Profile

Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. Its focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.

Contact Information

Website: www.auriniapharma.com
Main Phone: +1 250 708-4272
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CAN
Postal Code: V8Z 7X8

Issuer Information

Exchange: TSX
Employees: 16
NAICS: Pharmaceutical P
$ 4.62 $ 0.18 (4.05%)
Last Price 4.62 Change $ 0.18 Change % 4.05 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 4.45 High 4.62 Low 4.45 Prev Close 4.44
Last Trade Volume 200 52 Wk Hi 6.78 52 Wk Low 2.79
Market Cap 244 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 52,808,235.00 EPS (TTM) -0.76 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10.89 10.89 10.89 10.89
Low Target Price Estimate 10.89 10.89 10.89 10.89
Mean Target Price Estimate 10.89 10.89 10.89 10.89
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/29/16 03/29/16 03/29/16 03/29/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1